ATE192155T1 - Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE192155T1
ATE192155T1 AT95401311T AT95401311T ATE192155T1 AT E192155 T1 ATE192155 T1 AT E192155T1 AT 95401311 T AT95401311 T AT 95401311T AT 95401311 T AT95401311 T AT 95401311T AT E192155 T1 ATE192155 T1 AT E192155T1
Authority
AT
Austria
Prior art keywords
tetracyclic
production
pharmaceutical preparations
preparations containing
containing same
Prior art date
Application number
AT95401311T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Joel Vian
Bertrand Goument
Mark Millan
Valerie Audinot
Jean-Charles Schwartz
Pierre Sokoloff
Original Assignee
Adir
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir, Inst Nat Sante Rech Med filed Critical Adir
Application granted granted Critical
Publication of ATE192155T1 publication Critical patent/ATE192155T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95401311T 1994-06-08 1995-06-07 Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen ATE192155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9406985A FR2721027B1 (fr) 1994-06-08 1994-06-08 Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
ATE192155T1 true ATE192155T1 (de) 2000-05-15

Family

ID=9463983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95401311T ATE192155T1 (de) 1994-06-08 1995-06-07 Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (17)

Country Link
US (2) US5593989A (de)
EP (1) EP0686637B1 (de)
JP (1) JP3157418B2 (de)
CN (1) CN1050358C (de)
AT (1) ATE192155T1 (de)
AU (1) AU681780B2 (de)
CA (1) CA2151096C (de)
DE (1) DE69516457T2 (de)
DK (1) DK0686637T3 (de)
ES (1) ES2147825T3 (de)
FI (1) FI111948B (de)
FR (1) FR2721027B1 (de)
GR (1) GR3033762T3 (de)
NO (1) NO304741B1 (de)
NZ (1) NZ272298A (de)
PT (1) PT686637E (de)
ZA (1) ZA954738B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741074B1 (fr) * 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1998055454A2 (en) * 1997-06-05 1998-12-10 Takeda Chemical Industries, Ltd. Benzofurans and benzothophenes as suppressors of neurodegeneration
CA2522595A1 (en) * 2003-04-03 2004-10-28 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
FR2906249B1 (fr) 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4435231A (en) * 1982-03-31 1984-03-06 The United States Of America As Represented By The United States Department Of Energy Cold worked ferritic alloys and components
EP0161218B1 (de) 1984-05-10 1991-06-26 Ciba-Geigy Ag Benzo-(pyrano und thiopyrano)-pyridine
US4774243A (en) * 1985-12-24 1988-09-27 Merck & Co., Inc. Dopamine agonists for treating elevated intraocular pressure
US4792548A (en) * 1986-05-21 1988-12-20 Warner-Lambert Company Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use
US5294618A (en) * 1989-07-28 1994-03-15 Merck Sharp & Dohme Limited Octahydrobenzisoquinoline derivatives as antipsychotic agents
WO1993024471A1 (en) 1992-06-02 1993-12-09 Whitby Research, Inc. Substituted naphthoxazines useful as dopaminergics

Also Published As

Publication number Publication date
JP3157418B2 (ja) 2001-04-16
FR2721027A1 (fr) 1995-12-15
NO952249L (no) 1995-12-11
FI952802A0 (fi) 1995-06-07
NO304741B1 (no) 1999-02-08
ES2147825T3 (es) 2000-10-01
CA2151096A1 (fr) 1995-12-09
GR3033762T3 (en) 2000-10-31
EP0686637B1 (de) 2000-04-26
FI111948B (fi) 2003-10-15
JPH07330778A (ja) 1995-12-19
FR2721027B1 (fr) 1996-07-19
US5668142A (en) 1997-09-16
DE69516457D1 (de) 2000-05-31
AU2052395A (en) 1995-12-14
EP0686637A1 (de) 1995-12-13
NO952249D0 (no) 1995-06-07
US5593989A (en) 1997-01-14
CN1050358C (zh) 2000-03-15
DK0686637T3 (da) 2000-09-18
CN1120541A (zh) 1996-04-17
CA2151096C (fr) 2003-07-08
DE69516457T2 (de) 2001-01-18
PT686637E (pt) 2000-08-31
AU681780B2 (en) 1997-09-04
NZ272298A (en) 1996-05-28
FI952802L (fi) 1995-12-09
ZA954738B (en) 1996-01-26

Similar Documents

Publication Publication Date Title
FR2692264B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
DK0672412T3 (da) Anvendelse af 3,4-diphenylchromaner til fremstilling af et medikament til sænkning af cholesterolniveauer
ATE125537T1 (de) 1,4-disubstituierte piperazine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE210134T1 (de) Heterocyclisch substituierte imidazolidine, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen
YU32196A (sh) Upotreba jedinjenja za pripremanje leka korisnog za inhibiranje migracije vaskularnih ćelija glatkog mišića
DE59509395D1 (de) Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
ATE192155T1 (de) Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE3881714D1 (de) Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DK0717036T3 (da) Anvendelse af 5-acyl-1,4-dihydropyridiner til bekæmpelse af sygdomme i CNS
SE8904127D0 (sv) New biocyclic amino-substituted compounds
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
ATE198752T1 (de) Tetrazyclisch 1,4-oxazinverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE281452T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
HUT48818A (en) Process for production of analgetic medical preparatives containing as active substance derivatives of pirido-pirimidin or pirimido-pirimidin
FI810103L (fi) Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning
ES2121071T3 (es) Compuestos de oxazolidina y su empleo como medicamentos.
FR2677647B1 (fr) Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE281453T1 (de) 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE15031T1 (de) 1-(2,4-dichlorphenoxy)-3-(3,4-dimethoxy-betaphenethylamino)-2-propanol, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee